跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,747 条关于
“SIK”
全部
1,747
临床试验
1,197
药物
323
机构
25
资讯
202
7个月前
Nimbus Therapeutics Advances Novel SIK2 Inhibitors for Inflammatory Bowel Disease with Dual Anti-Inflammatory and Mucosal Healing Mechanism
去年
Onco3R Therapeutics Receives Regulatory Approval for First-in-Human Trial of Novel SIK3 Inhibitor O3R-5671
9个月前
Onco3R Therapeutics Reports Positive Phase 1 Data for Novel SIK3 Inhibitor O3R-5671 in Autoimmune Disease Treatment
4个月前
Coultreon Biopharma Secures $125M Series A to Advance Novel SIK3 Inhibitor for Autoimmune Diseases
上个月
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer to Advance First-in-Class SIK3 Inhibitor COL-5671
去年
Nimbus Therapeutics Names Abbas Kazimi as New CEO in Planned Leadership Transition
14天前
Healthcare Experts Call for Regulatory Reforms to Advance Precision Medicine and Patient Care in South Korea
去年
Nimbus Therapeutics Initiates First-in-Human Trial of NDI-219216 for MSI-H Tumors Resistant to Standard Therapies
上个月
NEJM Perspective Asks Whether AI Can Say "I Don't Know" as LLM Confabulation Rates Reach 99.6% on Fabricated Drug Names
2个月前
Kim V. Narry Becomes First Korean and Asian Recipient of HFSP Nakasone Award for Pioneering mRNA Tail Research
第 1 页,共 21 页
上一页
下一页